Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
11.95 1.23(11.47%) Jul 29, 4:00PM EDT
Prev Close:10.72
Open:11.86
Bid:11.75 x 200
Ask:12.13 x 100
1y Target Est:28.10
Beta:2.84
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:11.44 - 12.12
52wk Range:3.32 - 27.63
Volume:6,444,442
Avg Vol (3m):1,970,210
Market Cap:619.87M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARWRUp 11.47%619.87M
APNT6.94M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,177.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.94
Quarterly EPS Est (Jun-14) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback